Tissium is a mission-driven medical device company founded in 2013, headquartered in Paris, with a production facility in Roncq (near Lille) and an office in Boston. We are dedicated to creating a new era of body repair by leveraging our biopolymer platform to develop innovative solutions in surgery for a positive impact on patients' lives.
Tissium’s technology is based on research and intellectual property from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women's Hospital), who co-founded the company with Christophe Bancel (CEO) and Maria Pereira (Deputy CEO & Chief Innovation Officer).
We are developing polymers for atraumatic tissue repair in various applications. Today, these polymers are used for sutureless nerve repair, hernia repair, and cardiovascular sealing.
Since our inception, we have raised a total of 170 million euros. Our latest fundraising round, which concluded in April 2023, resulted in 50 million euros in additional funding. This infusion of capital provides us with the necessary resources to finance the commercialization of our first products.
TISSIUM is moving from a phase of GenAI experimentation to a more fundamental transformation: embedding automation and AI into how the company operates.
This is a founding position, backed by direct sponsorship from our executive team and a dedicated budget. You'll own both the strategy and the execution, identifying where digital creates value, building the solutions yourself, and progressively enabling teams across R&D, manufacturing, quality, regulatory, and commercial functions to operate with digital tools.
You won't be executing someone else's backlog. You'll have the autonomy to identify where AI and digital technologies can create the greatest value, the budget to bring in extra hands (freelance/contractor support) when a project calls for it, and direct access to leadership to challenge existing ways of working and turn opportunities into shipped solutions.
This role offers exposure to complex scientific and industrial challenges within a fast-growing MedTech company, placing you at the intersection of every function. As the organization scales, it offers a natural path toward leading a broader digital and AI function with increasing strategic influence.
This position reports to the VP, Portfolio Strategy, with direct sponsorship from Tissium's executive team on priorities and budget.
We're looking for a builder who drives change: technical enough to ship real tools yourself, and just as strong at getting people to actually use them.
In some cases, we may also request professional references (including contact details).
Intrigued? We’d love to hear from you! Apply today - we’re standing by for your resume!
👉 We believe that building an inclusive company starts with a diverse team. We value diversity and encourage applications from people of all backgrounds. We are committed to equal opportunity and do not tolerate discrimination of any kind, including on the basis of gender, gender identity or expression, sexual orientation, origin, family situation, age, beliefs, disability, health status, or any other characteristic protected by law.
Our recruitment process is designed to be simple, transparent, and conversation-driven. We prioritize human interaction and ensure that every application is reviewed carefully and fairly.

TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.